Milestone Pharmaceuticals, Inc. (MIST)
0.8097
-0.01
(-0.74%)
USD |
NASDAQ |
Oct 02, 16:00
0.8036
-0.01
(-0.75%)
After-Hours: 20:00
Milestone Pharmaceuticals Market Cap : 100.81M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 100.81M |
| October 01, 2026 | 101.55M |
| September 30, 2026 | 107.78M |
| September 29, 2026 | 102.09M |
| September 28, 2026 | 99.03M |
| September 25, 2026 | 98.15M |
| September 24, 2026 | 98.96M |
| September 23, 2026 | 107.32M |
| September 22, 2026 | 114.66M |
| September 21, 2026 | 114.26M |
| September 18, 2026 | 114.02M |
| September 17, 2026 | 114.49M |
| September 16, 2026 | 110.70M |
| September 15, 2026 | 115.50M |
| September 14, 2026 | 118.20M |
| September 11, 2026 | 122.02M |
| September 10, 2026 | 130.72M |
| September 09, 2026 | 133.21M |
| September 08, 2026 | 140.06M |
| September 04, 2026 | 149.40M |
| September 03, 2026 | 150.64M |
| September 02, 2026 | 146.91M |
| September 01, 2026 | 141.93M |
| August 31, 2026 | 144.42M |
| August 28, 2026 | 144.42M |
| Date | Value |
|---|---|
| August 27, 2026 | 148.15M |
| August 26, 2026 | 146.91M |
| August 25, 2026 | 144.42M |
| August 24, 2026 | 129.48M |
| August 21, 2026 | 131.35M |
| August 20, 2026 | 128.23M |
| August 19, 2026 | 134.46M |
| August 18, 2026 | 133.21M |
| August 17, 2026 | 136.95M |
| August 14, 2026 | 136.95M |
| August 13, 2026 | 133.21M |
| August 12, 2026 | 140.06M |
| August 11, 2026 | 158.11M |
| August 10, 2026 | 156.87M |
| August 07, 2026 | 151.89M |
| August 06, 2026 | 139.00M |
| August 05, 2026 | 134.87M |
| August 04, 2026 | 137.82M |
| August 03, 2026 | 131.93M |
| July 31, 2026 | 130.75M |
| July 30, 2026 | 135.46M |
| July 29, 2026 | 122.51M |
| July 28, 2026 | 126.04M |
| July 27, 2026 | 133.11M |
| July 24, 2026 | 136.64M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| InMed Pharmaceuticals, Inc. | 7.101M |
| NervGen Pharma Corp. | 189.41M |
| Clearmind Medicine, Inc. | 1.534M |
| Lexaria Bioscience Corp. | 4.759M |
| Target Group, Inc. (Canada) | 0.4319M |
Market Cap Related Metrics
| PS Ratio | 40.75 |
| Price to Book Value | 5.533 |
| Price | 0.8097 |
| Earnings Yield | -85.69% |